C
Chandrasekhar Nutalapati
Researcher at Nizam's Institute of Medical Sciences
Publications - 13
Citations - 83
Chandrasekhar Nutalapati is an academic researcher from Nizam's Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 10 publications receiving 37 citations.
Papers
More filters
Journal ArticleDOI
Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: a randomised, double blind, placebo controlled clinical study.
TL;DR: P. emblica aqueous extract significantly improved endothelial function, oxidative stress, systemic inflammation and lipid profile at both dosages tested, but especially at 500 mg twice daily, which may be used as an adjunct to conventional therapy in the management of metabolic syndrome.
Journal ArticleDOI
Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus - A Randomized, Double-Blind, Placebo-Controlled Clinical Study.
TL;DR: NEEM may significantly ameliorate hyperglycemia, endothelial dysfunction, and systemic inflammation, on top of what metformin could do, in subjects with T2DM.
Journal ArticleDOI
Effect of an aqueous extract of Terminalia chebula on endothelial dysfunction, systemic inflammation, and lipid profile in type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical study.
TL;DR: T. chebula (especially, 500 mg BID dose) significantly minimized the cardiovascular risk factors in patients with type 2 diabetes compared to placebo.
Journal ArticleDOI
Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
TL;DR: Addition of PCC, especially at 20 mg dose, significantly improves the efficacy of fish oil in addressing cardiovascular risk factors compared to fish oil given alone, and there were highly significant improvements in all the parameters tested.
Journal ArticleDOI
A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia.
Pingali Usharani,Chandrasekhar Nutalapati,Venkata K. Pokuri,Chiranjeevi Uday Kumar,Gangadhar Taduri +4 more
TL;DR: T. bellerica has the potential for treating hyperuricemia as it was devoid of any serious adverse effects in the present study and further studies are needed to confirm this potential.